₹126.57
Above FV▼ -63.9% against the close used
Model range ₹29.23 – ₹173.30
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Bear₹29.23Fair value₹126.57Bull₹173.30
FairClose
52-week traded range
52W low ₹151.7052W high ₹350.40
The 52-week range is measured from the stored price history, not estimated.
Trading above the consensus fair value
Saakshi Medtec N Panels L closed at ₹350.40, 176.8% above the consensus fair value of ₹126.57 drawn from 9 valuation models.
Financial DNA score 34/100 — Weak. P/E of 49.6x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
DCF Valuation
₹104.82
-70.1%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=4.2%, r=10%, tg=3%, n=10yr
Graham Number
₹99.70
-71.5%
√(22.5 × EPS × BVPS)
EPS=6.96, BVPS=63.48 · outside Graham range (P/E 49.6, P/B 5.5) — asset-light, treat as a rough floor
Graham Formula
₹109.22
-68.8%
EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate
g=4.2%, FD=7%
P/E Fair Value
₹154.16
-56.0%
EPS × 22.15x (sector P/E)
EPS=6.96, Sector P/E=22.15x
Peter Lynch (PEG)
₹29.23
-91.7%
EPS × Growth% (PEG = 1 is fair)
EPS=6.96, g=4.2%
EV/EBITDA
₹173.30
-50.5%
(EBITDA × 12.1x − Net Debt) ÷ Shares
EBITDA=270M
Book Value (P/B)
₹83.18
-76.3%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=63.48, ROE=11.8%, g=4.2%, r=10%
Reverse DCF
₹350.40
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 19.6% | Historical: 4.2%
Margin of Safety
₹87.73
-75.0%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=116.98, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.